Neuroendocrine control of metabolism

Gynecological Endocrinology

Volumn 28, Issue SUPPL.1, 2012, Pages 27-32

  Kuliczkowska Plaksej, J ^a   Milewicz, A ^a   Jakubowska, J ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

Adipokines; central appetite control; gut hormones

Indexed keywords

ADIPOCYTOKINE; AGOUTI RELATED PROTEIN; ALPHA INTERMEDIN; AMYLIN; BRAIN DERIVED NEUROTROPHIC FACTOR; CHOLECYSTOKININ; CILIARY NEUROTROPHIC FACTOR; DIPEPTIDYL PEPTIDASE IV INHIBITOR; ENDOCANNABINOID; ESTRADIOL; EXENDIN 4; GASTROINTESTINAL HORMONE; GHRELIN; GLUCAGON LIKE PEPTIDE 1; GONADOTROPIN; GROWTH HORMONE; INSULIN; LEPTIN; LIRAGLUTIDE; NEUROPEPTIDE; NEUROPEPTIDE Y; OXYNTOMODULIN; PANCREAS POLYPEPTIDE; PEPTIDE YY; PRAMLINTIDE; PROOPIOMELANOCORTIN; RIMONABANT; SOMATOMEDIN C; TESTOSTERONE; THYROID HORMONE;

ABDOMINAL OBESITY; ADIPOSE TISSUE; ADRENERGIC SYSTEM; AMYGDALOID NUCLEUS; ANOREXIA; ANOREXIA NERVOSA; ANXIETY DISORDER; ARCUATE NUCLEUS; BLOOD BRAIN BARRIER; BODY MASS; BRAIN STEM; CALORIC INTAKE; CELL NUCLEUS; CHOLINERGIC SYSTEM; DEPRESSION; DIABETES MELLITUS; DORSOMEDIAL HYPOTHALAMIC NUCLEUS; ENERGY BALANCE; ENERGY METABOLISM; FOOD INTAKE; HOMEOSTASIS; HUMAN; HYPERPHAGIA; HYPERTHYROIDISM; HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; HYPOTHALAMUS; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INSULIN RESISTANCE; INSULIN SENSITIVITY; INTEGRATION; LATERAL HYPOTHALAMUS; LIMBIC SYSTEM; LIPOLYSIS; LIVER; MESENCEPHALON; METABOLIC SYNDROME X; METABOLISM; MOLECULAR INTERACTION; MUSCLE; NEUROENDOCRINE SYSTEM; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; ORBITAL CORTEX; PANCREAS; PRIORITY JOURNAL; RECEPTOR BINDING; REVIEW; REWARD; RHOMBENCEPHALON; SIGNAL TRANSDUCTION; SOLITARY TRACT NUCLEUS; THALAMUS VENTRAL NUCLEUS; THYROID GLAND; VAGUS NERVE; WEIGHT CHANGE; WEIGHT REDUCTION;

ANIMALS; APPETITE REGULATION; BRAIN STEM; ENERGY METABOLISM; GASTROINTESTINAL HORMONES; HUMANS; HYPOTHALAMUS; NEUROSECRETORY SYSTEMS; REWARD;

EID: 84858038657     PISSN: 09513590     EISSN: 14730766     Source Type: Journal    
DOI: 10.3109/09513590.2012.651930     Document Type: Review

References (70)

1. Simpson KA, Martin NM, Bloom SR. Hypothalamic regulation of food intake and clinical therapeutic applications. Arq Bras Endocrinol Metabol 2009;53:120-128.
2. Gross PM. Circumventricular organ capillaries. Prog Brain Res 1992;91:219-233.
3. Suzuki K, Simpson KA, Minnion JS, Shillito JC, Bloom SR. The role of gut hormones and the hypothalamus in appetite regulation. Endocr J 2010;57:359-372.
4. Zac-Varghese S, Tan T, Bloom SR. Hormonal interactions between gut and brain. Discov Med 2010;10:543-552.
5. Leibowitz SF, Hammer NJ, Chang K. Hypothalamic paraventricular nucleus lesions produce overeating and obesity in the rat. Physiol Behav 1981;27:1031-1040.
6. Cone RD. Studies on the physiological functions of the melanocortin system. Endocr Rev 2006;27:736-749. (Pubitemid 44936057)
7. Tao YX. Molecular mechanisms of the neural melanocortin receptor dysfynction in severe early onset obesity. Mol Cell Endocrinol 2005;239:1-14.
8. Abbott CR, Rossi M, Wren AM, Murphy KG, Kennedy AR, Stanley SA, Zollner AN, et al. Evidence of an orexigenic role for cocaine- and amphetamine-regulated transcript after administration into discrete hypothalamic nuclei. Endocrinology 2001;142:3457-3463. (Pubitemid 32681753)
9. Wynne K, Stanley S, McGowan B, Bloom S. Appetite control. J Endocrinol 2005;184:291-318. (Pubitemid 40347231)
10. Bagnol D, Lu XY, Kaelin CB, Day HE, Ollmann M, Gantz I, Akil H, et al. Anatomy of an endogenous antagonist: relationship between Agouti-related protein and proopiomelanocortin in brain. J Neurosci 1999;19:RC26.
11. Bewick GA, Gardiner JV, Dhillo WS, Kent AS, White NE, Webster Z, Ghatei MA, Bloom SR. Post-embryonic ablation of AgRP neurons in mice leads to a lean, hypophagic phenotype. FASEB J 2005;19:1680-1682. (Pubitemid 41429528)
12. Belgardt BF, Okamura T, Brüning JC. Hormone and glucose signalling in POMC and AgRP neurons. J Physiol (Lond) 2009;587:5305-5314.
13. Xu B, Goulding EH, Zang K, Cepoi D, Cone RD, Jones KR, Tecott LH, Reichardt LF. Brain-derived neurotrophic factor regulates energy balance downstream of melanocortin-4 receptor. Nat Neurosci 2003;6:736-742. (Pubitemid 36792889)
14. Gooley JJ, Schomer A, Saper CB. The dorsomedial hypothalamic nucleus is critical for the expression of food-entrainable circadian rhythms. Nat Neurosci 2006;9:398-407. (Pubitemid 43290970)
15. Bailey EF. A tasty morsel: the role of the dorsal vagal complex in the regulation of food intake and swallowing. Focus on "BDNF/ TrkB signaling interacts with GABAergic system to inhibit rhythmic swallowing in the rat," by Bariohay et al. Am J Physiol Regul Integr Comp Physiol 2008;295:R1048-R1049.
16. Pagotto U, Marsicano G, Cota D, Lutz B, Pasquali R. The emerging role of the endocannabinoid system in endocrine regulation and energy balance. Endocr Rev 2006;27:73-100. (Pubitemid 43228239)
17. Ravinet Trillou C, Delgorge C, Menet C, Arnone M, Soubrié P. CB1 cannabinoid receptor knockout in mice leads to leanness, resistance to diet-induced obesity and enhanced leptin sensitivity. Int J Obes Relat Metab Disord 2004;28:640-648. (Pubitemid 38491158)
18. Gibbs J, Young RC, Smith GP. Cholecystokinin decreases food intake in rats. J Comp Physiol Psychol 1973;84:488-495.
19. Murphy KG, Dhillo WS, Bloom SR. Gut peptides in the regulation of food intake and energy homeostasis. Endocr Rev 2006;27:719-727. (Pubitemid 44936055)
20. Cummings DE, Overduin J. Gastrointestinal regulation of food intake. J Clin Invest 2007;117:13-23. (Pubitemid 46048445)
21. Chen J, Scott KA, Zhao Z, Moran TH, Bi S. Characterization of the feeding inhibition and neural activation produced by dorsomedial hypothalamic cholecystokinin administration. Neuroscience 2008;152:178-188.
22. Boguszewski CL, Paz-Filho G, Velloso LA. Neuroendocrine body weight regulation: integration between fat tissue, gastrointestinal tract, and the brain. Endokrynol Pol 2010;61:194-206.
23. Kojima M, Kangawa K. Ghrelin: structure and function. Physiol Rev 2005;85:495-522. (Pubitemid 40404635)
24. Asakawa A, Inui A, Yuzuriha H, Ueno N, Katsuura G, Fujimiya M, Fujino MA, et al. Characterization of the effects of pancreatic polypeptide in the regulation of energy balance. Gastroenterology 2003;124:1325-1336. (Pubitemid 36531807)
25. Batterham RL, Le Roux CW, Cohen MA, Park AJ, Ellis SM, Patterson M, Frost GS, et al. Pancreatic polypeptide reduces appetite and food intake in humans. J Clin Endocrinol Metab 2003;88:3989-3992. (Pubitemid 37034556)
26. Ashby D, Bloom SR. Recent progress in PYY research-an update report for 8th NPY meeting. Peptides 2007;28:198-202. (Pubitemid 46178463)
27. Moran TH, Dailey MJ. Minireview: Gut peptides: targets for antiobesity drug development? Endocrinology 2009;150:2526-2530.
28. Holst JJ. On the physiology of GIP and GLP-1. Horm Metab Res 2004;36:747-754. (Pubitemid 40115894)
29. Dakin CL, Small CJ, Batterham RL, Neary NM, Cohen MA, Patterson M, Ghatei MA, Bloom SR. Peripheral oxyntomodulin reduces food intake and body weight gain in rats. Endocrinology 2004;145:2687-2695. (Pubitemid 38686215)
30. Reda TK, Geliebter A, Pi-Sunyer FX. Amylin, food intake, and obesity. Obes Res 2002;10:1087-1091. (Pubitemid 135688927)
31. Rushing PA, Hagan MM, Seeley RJ, Lutz TA, Woods SC. Amylin: a novel action in the brain to reduce body weight. Endocrinology 2000;141:850-853. (Pubitemid 32250511)
32. Blüher S, Mantzoros CS. Leptin in humans: lessons from translational research. Am J Clin Nutr 2009;89:991S-997S.
33. Paz-Filho GJ, Volaco A, Suplicy HL, Radominski RB, Boguszewski CL. Decrease in leptin production by the adipose tissue in obesity associated with severe metabolic syndrome. Arq Bras Endocrinol Metabol 2009;53:1088-1095.
34. Oral EA, Simha V, Ruiz E, Andewelt A, Premkumar A, Snell P, Wagner AJ, et al. Leptin-replacement therapy for lipodystrophy. N Engl J Med 2002;346:570-578. (Pubitemid 34438818)
35. Morton GJ, Cummings DE, Baskin DG, Barsh GS, Schwartz MW. Central nervous system control of food intake and body weight. Nature 2006;443:289-295. (Pubitemid 44435142)
36. Schwartz MW, Porte D Jr. Diabetes, obesity, and the brain. Science 2005;307:375-379. (Pubitemid 40139972)
37. Kyrou I, Chrousos GP, Tsigos C. Stress, visceral obesity, and metabolic complications. Ann N Y Acad Sci 2006;1083:77-110. (Pubitemid 44955468)
38. Pasquali R, Vicennati V, Cacciari M, Pagotto U. The hypothalamic- pituitary- adrenal axis activity in obesity and the metabolic syndrome. Ann N Y Acad Sci 2006;1083:111-128. (Pubitemid 44955469)
39. Zakrzewska KE, Cusin I, Sainsbury A, Rohner-Jeanrenaud F, Jeanrenaud B. Glucocorticoids as counterregulatory hormones of leptin: toward an understanding of leptin resistance. Diabetes 1997;46:717-719. (Pubitemid 27143393)
40. Duclos M, Marquez Pereira P, Barat P, Gatta B, Roger P. Increased cortisol bioavailability, abdominal obesity, and the metabolic syndrome in obese women. Obes Res 2005;13:1157-1166.
41. Weigensberg MJ, Toledo-Corral CM, Goran MI. Association between the metabolic syndrome and serum cortisol in overweight Latino youth. J Clin Endocrinol Metab 2008;93:1372-1378. (Pubitemid 351519735)
42. Abraham NG, Brunner EJ, Eriksson JW, Robertson RP. Metabolic syndrome: psychosocial, neuroendocrine, and classical risk factors in type 2 diabetes. Ann N Y Acad Sci 2007;1113:256-275. (Pubitemid 350015014)
43. Chrousos GP. The role of stress and the hypothalamic-pituitary-adrenal axis in the pathogenesis of the metabolic syndrome: neuro-endocrine and target tissue-related causes. Int J Obes Relat Metab Disord 2000;24Suppl 2:S50-S55. (Pubitemid 30461948)
44. Lindmark S, Lönn L, Wiklund U, Tufvesson M, Olsson T, Eriksson JW. Dysregulation of the autonomic nervous system can be a link between visceral adiposity and insulin resistance. Obes Res 2005;13:717-728.
45. Lee ZS, Critchley JA, Tomlinson B, Young RP, Thomas GN, Cockram CS, Chan TY, Chan JC. Urinary epinephrine and norepinephrine interrelations with obesity, insulin, and the metabolic syndrome in Hong Kong Chinese. Metab Clin Exp 2001;50:135-143. (Pubitemid 32170823)
46. Huggett RJ, Scott EM, Gilbey SG, Bannister J, Mackintosh AF, Mary DA. Disparity of autonomic control in type 2 diabetes mellitus. Diabetologia 2005;48:172-179. (Pubitemid 40174670)
47. Huggett RJ, Hogarth AJ, Mackintosh AF, Mary DA. Sympathetic nerve hyperactivity in non-diabetic offspring of patients with type 2 diabetes mellitus. Diabetologia 2006;49:2741-2744.
48. Licht CM, Vreeburg SA, van Reedt Dortland AK, Giltay EJ, Hoogendijk WJ, DeRijk RH, Vogelzangs N, et al. Increased sympathetic and decreased parasympathetic activity rather than changes in hypothalamic-pituitary-adrenal axis activity is associated with metabolic abnormalities. J Clin Endocrinol Metab 2010;95:2458-2466.
49. Frontoni S, Bracaglia D, Baroni A, Pellegrini F, Perna M, Cicconetti E, Ciampittiello G, et al. Early autonomic dysfunction in glucose-tolerantbut insulin-resistant offspring of type 2 diabetic patients. Hypertension 2003;41:1223-1227. (Pubitemid 36706069)
50. Holt RI. Fetal programming of the growth hormone-insulin-like growth factor axis. Trends Endocrinol Metab 2002;13:392-397. (Pubitemid 36723592)
51. Brick DJ, Gerweck AV, Meenaghan E, Lawson EA, Misra M, Fazeli P, Johnson W, et al. Determinants of IGF1 and GH across the weight spectrum: from anorexia nervosa to obesity. Eur J Endocrinol 2010;163:185-191.
52. Osterstock G, Escobar P, Mitutsova V, Gouty-Colomer LA, Fontanaud P, Molino F, Fehrentz JA, et al. Ghrelin stimulation of growth hormone-releasing hormone neurons is direct in the arcuate nucleus. PLoS ONE 2010;5:e9159.
53. Hana V, Silha JV, Justova V, Lacinova Z, Stepan JJ, Murphy LJ. The effects of GH replacement in adult GH-deficient patients: changes in body composition without concomitant changes in the adipokines and insulin resistance. Clin Endocrinol (Oxf) 2004;60:442-450. (Pubitemid 38482506)
54. Tung YC, Ma M, Piper S, Coll A, O'Rahilly S, Yeo GS. Novel leptin-regulated genes revealed by transcriptional profiling of the hypothalamic paraventricular nucleus. J Neurosci 2008;28:12419-12426.
55. Gibney J, Wolthers T, Johannsson G, Umpleby AM, Ho KK. Growth hormone and testosterone interact positively to enhance protein and energy metabolism in hypopituitary men. Am J Physiol Endocrinol Metab 2005;289:E266-E271. (Pubitemid 41076627)
56. Klieverik LP, Coomans CP, Endert E, Sauerwein HP, Havekes LM, Voshol PJ, Rensen PC, et al. Thyroid hormone effects on whole-body energy homeostasis and tissue-specific fatty acid uptake in vivo. Endocrinology 2009;150:5639-5648.
57. Choi YH, Hartzell D, Azain MJ, Baile CA. TRH decreases food intake and increases water intake and body temperature in rats. Physiol Behav 2002;77:1-4. (Pubitemid 35245713)
58. Ishii S, Kamegai J, Tamura H, Shimizu T, Sugihara H, Oikawa S. Triiodothyronine (T3) stimulates food intake via enhanced hypothalamic AMP-activated kinase activity. Regul Pept 2008;151:164-169.
59. Ghamari-Langroudi M, Vella KR, Srisai D, Sugrue ML, Hollenberg AN, Cone RD. Regulation of thyrotropin-releasing hormone-expressing neurons in paraventricular nucleus of the hypothalamus by signals of adiposity. Mol Endocrinol 2010;24:2366-2381.
60. Rosenbaum M, Murphy EM, Heymsfield SB, Matthews DE, Leibel RL. Low dose leptin administration reverses effects of sustained weight-reduction on energy expenditure and circulating concentrations of thyroid hormones. J Clin Endocrinol Metab 2002;87:2391-2394. (Pubitemid 34521535)
61. Clément K, Vaisse C, Lahlou N, Cabrol S, Pelloux V, Cassuto D, Gourmelen M, et al. A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction. Nature 1998;392:398-401. (Pubitemid 28168737)
62. Allan CA, McLachlan RI. Age-related changes in testosterone and the role of replacement therapy in older men. Clin Endocrinol (Oxf) 2004;60:653-670. (Pubitemid 38788071)
63. Brown LM, Clegg DJ. Central effects of estradiol in the regulation of food intake, body weight, and adiposity. J Steroid Biochem Mol Biol 2010;122:65-73.
64. Andersson B, Mattsson LA, Hahn L, Mårin P, Lapidus L, Holm G, Bengtsson BA, Björntorp P. Estrogen replacement therapy decreases hyperandrogenicity and improves glucose homeostasis and plasma lipids in postmenopausal women with noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 1997;82:638-643. (Pubitemid 27068643)
65. Lee CC, Kasa-Vubu JZ, Supiano MA. Androgenicity and obesity are independently associated with insulin sensitivity in postmenopausal women. Metab Clin Exp 2004;53:507-512. (Pubitemid 38419196)
66. Santollo J, Eckel LA. Estradiol decreases the orexigenic effect of neuropeptide Y, but not agouti-related protein, in ovariectomized rats. Behav Brain Res 2008;191:173-177.
67. Clegg DJ, Brown LM, Zigman JM, Kemp CJ, Strader AD, Benoit SC, Woods SC, et al. Estradiol-dependent decrease in the orexigenic potency of ghrelin in female rats. Diabetes 2007;56:1051-1058. (Pubitemid 46525056)
68. Clegg DJ, Brown LM, Woods SC, Benoit SC. Gonadal hormones determine sensitivity to central leptin and insulin. Diabetes 2006;55:978-987. (Pubitemid 44100172)
69. Ainslie DA, Morris MJ, Wittert G, Turnbull H, Proietto J, Thorburn AW. Estrogen deficiency causes central leptin insensitivity and increased hypothalamic neuropeptide Y. Int J Obes Relat Metab Disord 2001;25:1680-1688. (Pubitemid 33052080)
70. Rivier C, Rivier J, Vale W. Stress-induced inhibition of reproductive functions: role of endogenous corticotropin-releasing factor. Science 1986;231:607-609. (Pubitemid 16088944)